|
SF3A3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.159600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.380790E-03 |
| Normal-vs-Stage2 |
2.494400E-02 |
| Normal-vs-Stage3 |
3.111700E-02 |
| Normal-vs-Stage4 |
5.774000E-01 |
| Stage1-vs-Stage2 |
8.753800E-01 |
| Stage1-vs-Stage3 |
8.621000E-01 |
| Stage1-vs-Stage4 |
1.481200E-01 |
| Stage2-vs-Stage3 |
7.393200E-01 |
| Stage2-vs-Stage4 |
2.064800E-01 |
| Stage3-vs-Stage4 |
3.015600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.042890E-03 |
| Normal-vs-AfricanAmerican |
4.724000E-03 |
| Normal-vs-Asian |
5.662600E-01 |
| Caucasian-vs-AfricanAmerican |
9.621000E-01 |
| Caucasian-vs-Asian |
7.091600E-01 |
| AfricanAmerican-vs-Asian |
6.398800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.25419999999788E-05 |
| Normal-vs-Female |
4.634800E-01 |
| Male-vs-Female |
2.703700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.584500E-02 |
| Normal-vs-Extreme_Weight |
2.41970000000036E-05 |
| Normal-vs-Obese |
1.264360E-01 |
| Normal-vs-Extreme_Obese |
1.318030E-03 |
| Normal_Weight-vs-Extreme_Weight |
1.743590E-01 |
| Normal_Weight-vs-Obese |
8.078600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.693600E-01 |
| Extreme_Weight-vs-Obese |
1.675010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.472600E-01 |
| Obese-vs-Extreme_Obese |
1.650570E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.921400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.102900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.075880E-03 |
| Normal-vs-Age(81-100Yrs) |
4.393500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.273000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.694400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.391800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.422200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.179240E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.490200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.211040E-04 |
| Normal-VS-Type2 PRCC |
3.292300E-02 |
| Normal-VS-KIRP CIMP |
6.667600E-01 |
| Normal-VS-Unclassified PRCC |
1.721560E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.560200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.323000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.647560E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.031400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.539600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.928800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.06759999999973E-05 |
| Normal-vs-N1 |
8.408200E-01 |
| Normal-vs-N2 |
7.733400E-01 |
| N0-vs-N1 |
9.297800E-03 |
| N0-vs-N2 |
5.709200E-01 |
| N1-vs-N2 |
7.586200E-01 |
|
|
